期刊文献+

糖尿病心脏自主神经病变程度和心肌缺血发生的关系探究 被引量:3

下载PDF
导出
摘要 目的探讨糖尿病心脏自主神经病变(DCAN)程度同心肌缺血发生之间的关系,为今后的临床诊治工作提供可靠的参考依据。方法随机抽取在2009年11月—2012年11月间该院收治的2型糖尿病临床患者病例98例,而后按照心血管自主神经功能试验评分结果将患者分成DCAN正常组,DCAN早期组,DCAN确诊组,DCAN严重组。而后对比分析各组患者的24h动态心电检测结果。结果统计发现,各组患者无痛性ST段压低发生率存在明显差异,以DCAN严重组最高;DCAN正常组心肌缺血一般在上午发生,而DCAN组患者的心肌缺血弥散在全天。结论 DCAN会对糖尿病患者心肌缺血的发生产生明显的影响,且DCAN越严重,心肌缺血的发生率以及严重性也就越高,值得临床关注。
作者 王洁
出处 《中外医疗》 2013年第11期80-80,82,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献6

二级参考文献66

共引文献62

同被引文献25

  • 1Lin-Zhong Cui,Biao Wang,Li-Yan Chen,Jie Zhou.The effect of ischemic precondition to IL-6 on rat liver ischemiareperfusion injury in transplantation[J].Asian Pacific Journal of Tropical Medicine,2013,6(5):395-399. 被引量:10
  • 2宁光.糖尿病神经病变的诊断和治疗[J].国际内分泌代谢杂志,2006,26(3). 被引量:107
  • 3Szijiarto A, Czigany Z, Turoczi Z, et al. Remote ischemic perconditioning-a simple, low-risk method to decrease is- chemic reperfusion injury: Models, protocols and mecha- nistic background. A review[J]. Journal of Surgical Research, 2012,178(2):797-806.
  • 4Zairis M N, Papadaki O, Makrygiannis S, et al. Influence of diabetes mellitus on intravenous thrombolysis effective- ness in patients with ST elevation myocardial infarction[J]. Journal of the American College of Cardiology, 2009,41(6): 343-353.
  • 5Lee B C, Lee H J, Chung J H. Peroxisome proliferator-ac- tivated reeeptor-:/2 Prol2Ala polymorphism is associatedwith reduced risk for ischemic stroke with type 2 diabetes[J]. Neuroscience Letters, 2010,410(2) : 141-145.
  • 6Grauslund J, Jorgensen TM, Nybo M, et al. Risk factors for mortality and ischemie heart disease in patients with long-term type 1 diabetes [J]. Journal of Diabetes and its Comolications,2010,24(2):223-228.
  • 7Nakamura Y,Morishita R,Higaki J. Expression of local hepatocyte growth factor system in vascular tissues[J].{H}Biochemical and Biophysical Research Communications,1995,(02):483-488.
  • 8Kuzuya T,Nakagawa S,Satoh J. Report of the committee on the classification and diagnostic criteria of diabetes mellitus[J].{H}Diabetes Research and Clinical Practice,2002,(01):65-85.
  • 9Malik M. Heart rate variability:standards of measurement,physiological interpretation and clinical use.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology[J].{H}CIRCULATION,1996,(05):1043-1065.
  • 10Wang X,Zhou Y,Kim HP. Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells[J].{H}Journal of Biological Chemistry,2004,(07):5237-5243.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部